Incyte Corp
NASDAQ:INCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Incyte Corp
NASDAQ:INCY
|
US |
|
Healthcare Services Group Inc
NASDAQ:HCSG
|
US |
|
Ionis Pharmaceuticals Inc
NASDAQ:IONS
|
US |
|
Hudson Global Inc
NASDAQ:HSON
|
US |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
mBank SA
OTC:MBAKF
|
PL |
|
Ionic Rare Earths Ltd
ASX:IXR
|
AU |
|
MGM Resorts International
NYSE:MGM
|
US |
Wall St Price Targets
INCY Price Targets Summary
Incyte Corp
According to Wall Street analysts, the average 1-year price target for INCY is 110.3 USD with a low forecast of 72.83 USD and a high forecast of 141.75 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INCY's stock price target?
Price Target
110.3
USD
According to Wall Street analysts, the average 1-year price target for INCY is 110.3 USD with a low forecast of 72.83 USD and a high forecast of 141.75 USD.
What is the Revenue forecast for Incyte Corp?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Incyte Corp?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 73%. The projected CAGR for the next 8 years is 8%.
What is the Net Income forecast for Incyte Corp?
Projected CAGR
4%
The compound annual growth rate for Net Income over the next 8 years is 4%.
